nodes	percent_of_prediction	percent_of_DWPC	metapath
Tranexamic Acid—SLC15A2—multiple sclerosis	0.826	1	CbGaD
Tranexamic Acid—PLG—amb2 Integrin signaling—SELPLG—multiple sclerosis	0.0069	0.118	CbGpPWpGaD
Tranexamic Acid—PLG—p75(NTR)-mediated signaling—LINGO1—multiple sclerosis	0.00351	0.06	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet degranulation—PLEK—multiple sclerosis	0.00205	0.035	CbGpPWpGaD
Tranexamic Acid—PLG—retina—multiple sclerosis	0.00203	0.211	CbGeAlD
Tranexamic Acid—PLG—Response to elevated platelet cytosolic Ca2+—PLEK—multiple sclerosis	0.00195	0.0333	CbGpPWpGaD
Tranexamic Acid—PLG—Syndecan-4-mediated signaling events—CCL5—multiple sclerosis	0.00167	0.0286	CbGpPWpGaD
Tranexamic Acid—PLG—spinal cord—multiple sclerosis	0.00131	0.136	CbGeAlD
Tranexamic Acid—PLG—amb2 Integrin signaling—ICAM1—multiple sclerosis	0.00129	0.022	CbGpPWpGaD
Tranexamic Acid—PLG—Vitamin B12 Metabolism—CCL5—multiple sclerosis	0.00115	0.0197	CbGpPWpGaD
Tranexamic Acid—PLG—nervous system—multiple sclerosis	0.0011	0.115	CbGeAlD
Tranexamic Acid—PLG—central nervous system—multiple sclerosis	0.00106	0.111	CbGeAlD
Tranexamic Acid—PLG—Vitamin B12 Metabolism—APOE—multiple sclerosis	0.000944	0.0161	CbGpPWpGaD
Tranexamic Acid—PLG—p75(NTR)-mediated signaling—BDNF—multiple sclerosis	0.000943	0.0161	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—PLEK—multiple sclerosis	0.000909	0.0155	CbGpPWpGaD
Tranexamic Acid—PLG—Folate Metabolism—IL4—multiple sclerosis	0.000908	0.0155	CbGpPWpGaD
Tranexamic Acid—PLG—Vitamin B12 Metabolism—ICAM1—multiple sclerosis	0.000886	0.0151	CbGpPWpGaD
Tranexamic Acid—PLG—brain—multiple sclerosis	0.000844	0.0878	CbGeAlD
Tranexamic Acid—PLG—Syndecan-4-mediated signaling events—MMP9—multiple sclerosis	0.000823	0.0141	CbGpPWpGaD
Tranexamic Acid—PLG—Activation of Matrix Metalloproteinases—MMP9—multiple sclerosis	0.000823	0.0141	CbGpPWpGaD
Tranexamic Acid—PLG—amb2 Integrin signaling—MMP9—multiple sclerosis	0.000823	0.0141	CbGpPWpGaD
Tranexamic Acid—PLG—Vitamin B12 Metabolism—CCL2—multiple sclerosis	0.000793	0.0135	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—MERTK—multiple sclerosis	0.000758	0.013	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—SELPLG—multiple sclerosis	0.000758	0.013	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—CD58—multiple sclerosis	0.000758	0.013	CbGpPWpGaD
Tranexamic Acid—PLG—Vitamin B12 Metabolism—ALB—multiple sclerosis	0.000739	0.0126	CbGpPWpGaD
Tranexamic Acid—PLG—Folate Metabolism—ICAM1—multiple sclerosis	0.000721	0.0123	CbGpPWpGaD
Tranexamic Acid—PLG—Degradation of the extracellular matrix—SPP1—multiple sclerosis	0.000683	0.0117	CbGpPWpGaD
Tranexamic Acid—PLG—Vitamin B12 Metabolism—IFNG—multiple sclerosis	0.000674	0.0115	CbGpPWpGaD
Tranexamic Acid—PLG—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP9—multiple sclerosis	0.000662	0.0113	CbGpPWpGaD
Tranexamic Acid—SLC15A2—retina—multiple sclerosis	0.00065	0.0676	CbGeAlD
Tranexamic Acid—PLG—Folate Metabolism—CCL2—multiple sclerosis	0.000645	0.011	CbGpPWpGaD
Tranexamic Acid—PLG—amb2 Integrin signaling—TNF—multiple sclerosis	0.000634	0.0108	CbGpPWpGaD
Tranexamic Acid—PLG—Vitamin B12 Metabolism—IL1B—multiple sclerosis	0.000602	0.0103	CbGpPWpGaD
Tranexamic Acid—PLG—Folate Metabolism—ALB—multiple sclerosis	0.000601	0.0103	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—CD28—multiple sclerosis	0.000592	0.0101	CbGpPWpGaD
Tranexamic Acid—PLG—Selenium Micronutrient Network—ICAM1—multiple sclerosis	0.000573	0.00979	CbGpPWpGaD
Tranexamic Acid—PLG—Folate Metabolism—IFNG—multiple sclerosis	0.000549	0.00937	CbGpPWpGaD
Tranexamic Acid—PLG—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—TGFB1—multiple sclerosis	0.000546	0.00933	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000535	0.00914	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet degranulation—ALB—multiple sclerosis	0.000516	0.00881	CbGpPWpGaD
Tranexamic Acid—PLG—Selenium Micronutrient Network—CCL2—multiple sclerosis	0.000513	0.00876	CbGpPWpGaD
Tranexamic Acid—PLG—amb2 Integrin signaling—IL6—multiple sclerosis	0.000511	0.00874	CbGpPWpGaD
Tranexamic Acid—PLG—Response to elevated platelet cytosolic Ca2+—ALB—multiple sclerosis	0.000491	0.00839	CbGpPWpGaD
Tranexamic Acid—PLG—Folate Metabolism—IL1B—multiple sclerosis	0.000489	0.00836	CbGpPWpGaD
Tranexamic Acid—PLG—Folate Metabolism—IL2—multiple sclerosis	0.000488	0.00833	CbGpPWpGaD
Tranexamic Acid—PLG—Selenium Micronutrient Network—ALB—multiple sclerosis	0.000478	0.00816	CbGpPWpGaD
Tranexamic Acid—SLC15A2—medulla oblongata—multiple sclerosis	0.00047	0.0489	CbGeAlD
Tranexamic Acid—PLG—Hemostasis—PLEK—multiple sclerosis	0.000469	0.008	CbGpPWpGaD
Tranexamic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—MAPK1—multiple sclerosis	0.000466	0.00796	CbGpPWpGaD
Tranexamic Acid—SLC15A2—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000456	0.00778	CbGpPWpGaD
Tranexamic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—TNF—multiple sclerosis	0.000443	0.00758	CbGpPWpGaD
Tranexamic Acid—PLG—Vitamin B12 Metabolism—TNF—multiple sclerosis	0.000436	0.00746	CbGpPWpGaD
Tranexamic Acid—PLG—Selenium Micronutrient Network—IFNG—multiple sclerosis	0.000436	0.00745	CbGpPWpGaD
Tranexamic Acid—SLC15A2—midbrain—multiple sclerosis	0.000429	0.0447	CbGeAlD
Tranexamic Acid—PLG—Signaling by PDGF—CD86—multiple sclerosis	0.000423	0.00722	CbGpPWpGaD
Tranexamic Acid—SLC15A2—spinal cord—multiple sclerosis	0.000419	0.0436	CbGeAlD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000406	0.00693	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—ITGA4—multiple sclerosis	0.000402	0.00686	CbGpPWpGaD
Tranexamic Acid—PLG—Selenium Micronutrient Network—IL1B—multiple sclerosis	0.000389	0.00664	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—SPP1—multiple sclerosis	0.000385	0.00658	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—SLC30A7—multiple sclerosis	0.000369	0.0063	CbGpPWpGaD
Tranexamic Acid—PLG—Degradation of the extracellular matrix—MMP9—multiple sclerosis	0.000363	0.00621	CbGpPWpGaD
Tranexamic Acid—PLG—Folate Metabolism—TNF—multiple sclerosis	0.000355	0.00607	CbGpPWpGaD
Tranexamic Acid—SLC15A2—nervous system—multiple sclerosis	0.000353	0.0367	CbGeAlD
Tranexamic Acid—PLG—Vitamin B12 Metabolism—IL6—multiple sclerosis	0.000352	0.00602	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—VCAM1—multiple sclerosis	0.000349	0.00597	CbGpPWpGaD
Tranexamic Acid—SLC15A2—central nervous system—multiple sclerosis	0.00034	0.0354	CbGeAlD
Tranexamic Acid—SLC15A2—cerebellum—multiple sclerosis	0.000332	0.0346	CbGeAlD
Tranexamic Acid—PLG—Hemostasis—SELE—multiple sclerosis	0.00033	0.00564	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet degranulation—TGFB1—multiple sclerosis	0.000326	0.00557	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000321	0.00548	CbGpPWpGaD
Tranexamic Acid—SLC15A2—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000318	0.00544	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—IL2RA—multiple sclerosis	0.000316	0.0054	CbGpPWpGaD
Tranexamic Acid—PLG—Response to elevated platelet cytosolic Ca2+—TGFB1—multiple sclerosis	0.000311	0.00531	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—CD80—multiple sclerosis	0.000308	0.00527	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—PABPC1—multiple sclerosis	0.000298	0.00509	CbGpPWpGaD
Tranexamic Acid—PLG—Folate Metabolism—IL6—multiple sclerosis	0.000287	0.0049	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—SPP1—multiple sclerosis	0.000286	0.00489	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000283	0.00484	CbGpPWpGaD
Tranexamic Acid—PLG—Selenium Micronutrient Network—TNF—multiple sclerosis	0.000282	0.00482	CbGpPWpGaD
Tranexamic Acid—Abdominal pain—Cladribine—multiple sclerosis	0.00028	0.00265	CcSEcCtD
Tranexamic Acid—Back pain—Mitoxantrone—multiple sclerosis	0.000276	0.00261	CcSEcCtD
Tranexamic Acid—Acute coronary syndrome—Triamcinolone—multiple sclerosis	0.000271	0.00257	CcSEcCtD
Tranexamic Acid—Acute coronary syndrome—Methylprednisolone—multiple sclerosis	0.000271	0.00257	CcSEcCtD
Tranexamic Acid—Haemoglobin—Prednisolone—multiple sclerosis	0.00027	0.00256	CcSEcCtD
Tranexamic Acid—SLC15A2—brain—multiple sclerosis	0.00027	0.0281	CbGeAlD
Tranexamic Acid—Myocardial infarction—Triamcinolone—multiple sclerosis	0.00027	0.00256	CcSEcCtD
Tranexamic Acid—Myocardial infarction—Methylprednisolone—multiple sclerosis	0.000269	0.00255	CcSEcCtD
Tranexamic Acid—Hypotension—Azathioprine—multiple sclerosis	0.000269	0.00255	CcSEcCtD
Tranexamic Acid—PLG—Metabolism of proteins—RPL5—multiple sclerosis	0.000269	0.00459	CbGpPWpGaD
Tranexamic Acid—Haemorrhage—Prednisolone—multiple sclerosis	0.000269	0.00255	CcSEcCtD
Tranexamic Acid—Polyuria—Methotrexate—multiple sclerosis	0.000269	0.00255	CcSEcCtD
Tranexamic Acid—Ill-defined disorder—Mitoxantrone—multiple sclerosis	0.000264	0.00251	CcSEcCtD
Tranexamic Acid—Anaemia—Mitoxantrone—multiple sclerosis	0.000263	0.0025	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Azathioprine—multiple sclerosis	0.000262	0.00248	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Cladribine—multiple sclerosis	0.000261	0.00247	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—TYK2—multiple sclerosis	0.00026	0.00445	CbGpPWpGaD
Tranexamic Acid—Visual impairment—Prednisolone—multiple sclerosis	0.000259	0.00245	CcSEcCtD
Tranexamic Acid—Malaise—Mitoxantrone—multiple sclerosis	0.000257	0.00244	CcSEcCtD
Tranexamic Acid—Asthenia—Cladribine—multiple sclerosis	0.000254	0.00241	CcSEcCtD
Tranexamic Acid—Visual disturbance—Methotrexate—multiple sclerosis	0.000249	0.00236	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.000248	0.00235	CcSEcCtD
Tranexamic Acid—Haemoglobin—Triamcinolone—multiple sclerosis	0.000248	0.00235	CcSEcCtD
Tranexamic Acid—Haemoglobin—Methylprednisolone—multiple sclerosis	0.000248	0.00235	CcSEcCtD
Tranexamic Acid—Haemorrhage—Triamcinolone—multiple sclerosis	0.000247	0.00234	CcSEcCtD
Tranexamic Acid—Convulsion—Mitoxantrone—multiple sclerosis	0.000247	0.00234	CcSEcCtD
Tranexamic Acid—Haemorrhage—Methylprednisolone—multiple sclerosis	0.000247	0.00234	CcSEcCtD
Tranexamic Acid—Acute coronary syndrome—Dexamethasone—multiple sclerosis	0.000246	0.00233	CcSEcCtD
Tranexamic Acid—Acute coronary syndrome—Betamethasone—multiple sclerosis	0.000246	0.00233	CcSEcCtD
Tranexamic Acid—Myocardial infarction—Betamethasone—multiple sclerosis	0.000245	0.00232	CcSEcCtD
Tranexamic Acid—Myocardial infarction—Dexamethasone—multiple sclerosis	0.000245	0.00232	CcSEcCtD
Tranexamic Acid—Anaphylactoid reaction—Methotrexate—multiple sclerosis	0.000244	0.00231	CcSEcCtD
Tranexamic Acid—Myalgia—Mitoxantrone—multiple sclerosis	0.000243	0.0023	CcSEcCtD
Tranexamic Acid—Chest pain—Mitoxantrone—multiple sclerosis	0.000243	0.0023	CcSEcCtD
Tranexamic Acid—Arthralgia—Mitoxantrone—multiple sclerosis	0.000243	0.0023	CcSEcCtD
Tranexamic Acid—Diarrhoea—Cladribine—multiple sclerosis	0.000242	0.0023	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—LINGO1—multiple sclerosis	0.000242	0.00413	CbGpPWpGaD
Tranexamic Acid—Cerebrovascular accident—Methotrexate—multiple sclerosis	0.000241	0.00228	CcSEcCtD
Tranexamic Acid—Arrhythmia—Prednisolone—multiple sclerosis	0.00024	0.00227	CcSEcCtD
Tranexamic Acid—Discomfort—Mitoxantrone—multiple sclerosis	0.00024	0.00227	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—ITGA4—multiple sclerosis	0.000239	0.00408	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—ICAM1—multiple sclerosis	0.000238	0.00406	CbGpPWpGaD
Tranexamic Acid—Visual impairment—Methylprednisolone—multiple sclerosis	0.000238	0.00225	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Azathioprine—multiple sclerosis	0.000237	0.00225	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—IFNB1—multiple sclerosis	0.000237	0.00405	CbGpPWpGaD
Tranexamic Acid—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.000235	0.00223	CcSEcCtD
Tranexamic Acid—Dizziness—Cladribine—multiple sclerosis	0.000234	0.00222	CcSEcCtD
Tranexamic Acid—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.000233	0.0022	CcSEcCtD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000231	0.00395	CbGpPWpGaD
Tranexamic Acid—Eye disorder—Methylprednisolone—multiple sclerosis	0.00023	0.00218	CcSEcCtD
Tranexamic Acid—Cardiac disorder—Methylprednisolone—multiple sclerosis	0.000229	0.00217	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—ALB—multiple sclerosis	0.000229	0.00391	CbGpPWpGaD
Tranexamic Acid—PLG—Selenium Micronutrient Network—IL6—multiple sclerosis	0.000228	0.00389	CbGpPWpGaD
Tranexamic Acid—Abdominal pain—Azathioprine—multiple sclerosis	0.000228	0.00216	CcSEcCtD
Tranexamic Acid—Haemoglobin—Dexamethasone—multiple sclerosis	0.000225	0.00214	CcSEcCtD
Tranexamic Acid—Haemoglobin—Betamethasone—multiple sclerosis	0.000225	0.00214	CcSEcCtD
Tranexamic Acid—Vomiting—Cladribine—multiple sclerosis	0.000225	0.00213	CcSEcCtD
Tranexamic Acid—Haemorrhage—Betamethasone—multiple sclerosis	0.000224	0.00212	CcSEcCtD
Tranexamic Acid—Haemorrhage—Dexamethasone—multiple sclerosis	0.000224	0.00212	CcSEcCtD
Tranexamic Acid—Angiopathy—Methylprednisolone—multiple sclerosis	0.000224	0.00212	CcSEcCtD
Tranexamic Acid—Immune system disorder—Methylprednisolone—multiple sclerosis	0.000223	0.00211	CcSEcCtD
Tranexamic Acid—Mediastinal disorder—Methylprednisolone—multiple sclerosis	0.000222	0.00211	CcSEcCtD
Tranexamic Acid—Headache—Cladribine—multiple sclerosis	0.000222	0.0021	CcSEcCtD
Tranexamic Acid—Arrhythmia—Triamcinolone—multiple sclerosis	0.000221	0.00209	CcSEcCtD
Tranexamic Acid—Arrhythmia—Methylprednisolone—multiple sclerosis	0.00022	0.00209	CcSEcCtD
Tranexamic Acid—Hypotension—Mitoxantrone—multiple sclerosis	0.000217	0.00206	CcSEcCtD
Tranexamic Acid—Ill-defined disorder—Prednisolone—multiple sclerosis	0.000217	0.00206	CcSEcCtD
Tranexamic Acid—Visual impairment—Dexamethasone—multiple sclerosis	0.000216	0.00205	CcSEcCtD
Tranexamic Acid—Visual impairment—Betamethasone—multiple sclerosis	0.000216	0.00205	CcSEcCtD
Tranexamic Acid—Acute coronary syndrome—Prednisone—multiple sclerosis	0.000214	0.00203	CcSEcCtD
Tranexamic Acid—Myocardial infarction—Prednisone—multiple sclerosis	0.000213	0.00202	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Azathioprine—multiple sclerosis	0.000212	0.00201	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000212	0.00201	CcSEcCtD
Tranexamic Acid—Malaise—Prednisolone—multiple sclerosis	0.000211	0.002	CcSEcCtD
Tranexamic Acid—Nausea—Cladribine—multiple sclerosis	0.00021	0.00199	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—TAGAP—multiple sclerosis	0.00021	0.00358	CbGpPWpGaD
Tranexamic Acid—Eye disorder—Dexamethasone—multiple sclerosis	0.000209	0.00199	CcSEcCtD
Tranexamic Acid—Eye disorder—Betamethasone—multiple sclerosis	0.000209	0.00199	CcSEcCtD
Tranexamic Acid—Back pain—Triamcinolone—multiple sclerosis	0.000208	0.00197	CcSEcCtD
Tranexamic Acid—Dyspnoea—Mitoxantrone—multiple sclerosis	0.000207	0.00197	CcSEcCtD
Tranexamic Acid—Loss of consciousness—Prednisolone—multiple sclerosis	0.000206	0.00195	CcSEcCtD
Tranexamic Acid—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000205	0.00194	CcSEcCtD
Tranexamic Acid—Angiopathy—Betamethasone—multiple sclerosis	0.000203	0.00193	CcSEcCtD
Tranexamic Acid—Angiopathy—Dexamethasone—multiple sclerosis	0.000203	0.00193	CcSEcCtD
Tranexamic Acid—Convulsion—Prednisolone—multiple sclerosis	0.000203	0.00192	CcSEcCtD
Tranexamic Acid—Fatigue—Mitoxantrone—multiple sclerosis	0.000201	0.0019	CcSEcCtD
Tranexamic Acid—Arrhythmia—Betamethasone—multiple sclerosis	0.0002	0.0019	CcSEcCtD
Tranexamic Acid—Arrhythmia—Dexamethasone—multiple sclerosis	0.0002	0.0019	CcSEcCtD
Tranexamic Acid—Ill-defined disorder—Triamcinolone—multiple sclerosis	0.0002	0.00189	CcSEcCtD
Tranexamic Acid—Ill-defined disorder—Methylprednisolone—multiple sclerosis	0.000199	0.00189	CcSEcCtD
Tranexamic Acid—Diarrhoea—Azathioprine—multiple sclerosis	0.000197	0.00187	CcSEcCtD
Tranexamic Acid—PLG—Metabolism of proteins—BCHE—multiple sclerosis	0.000197	0.00336	CbGpPWpGaD
Tranexamic Acid—Discomfort—Prednisolone—multiple sclerosis	0.000197	0.00186	CcSEcCtD
Tranexamic Acid—Haemoglobin—Prednisone—multiple sclerosis	0.000196	0.00186	CcSEcCtD
Tranexamic Acid—Abdominal discomfort—Methotrexate—multiple sclerosis	0.000195	0.00185	CcSEcCtD
Tranexamic Acid—Haemorrhage—Prednisone—multiple sclerosis	0.000195	0.00185	CcSEcCtD
Tranexamic Acid—Malaise—Triamcinolone—multiple sclerosis	0.000194	0.00184	CcSEcCtD
Tranexamic Acid—Malaise—Methylprednisolone—multiple sclerosis	0.000194	0.00183	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000192	0.00182	CcSEcCtD
Tranexamic Acid—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000191	0.00181	CcSEcCtD
Tranexamic Acid—Dizziness—Azathioprine—multiple sclerosis	0.00019	0.0018	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.00019	0.0018	CcSEcCtD
Tranexamic Acid—Loss of consciousness—Triamcinolone—multiple sclerosis	0.000189	0.00179	CcSEcCtD
Tranexamic Acid—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.000189	0.00179	CcSEcCtD
Tranexamic Acid—Convulsion—Triamcinolone—multiple sclerosis	0.000186	0.00177	CcSEcCtD
Tranexamic Acid—Convulsion—Methylprednisolone—multiple sclerosis	0.000186	0.00176	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	0.000185	0.00317	CbGpPWpGaD
Tranexamic Acid—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000184	0.00174	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—S1PR1—multiple sclerosis	0.000183	0.00313	CbGpPWpGaD
Tranexamic Acid—Myalgia—Triamcinolone—multiple sclerosis	0.000183	0.00174	CcSEcCtD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000183	0.00313	CbGpPWpGaD
Tranexamic Acid—Vomiting—Azathioprine—multiple sclerosis	0.000183	0.00173	CcSEcCtD
Tranexamic Acid—Myalgia—Methylprednisolone—multiple sclerosis	0.000183	0.00173	CcSEcCtD
Tranexamic Acid—Arthralgia—Methylprednisolone—multiple sclerosis	0.000183	0.00173	CcSEcCtD
Tranexamic Acid—Eye disorder—Prednisone—multiple sclerosis	0.000182	0.00173	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—STAT3—multiple sclerosis	0.000182	0.00311	CbGpPWpGaD
Tranexamic Acid—Flushing—Prednisone—multiple sclerosis	0.000181	0.00172	CcSEcCtD
Tranexamic Acid—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000181	0.00172	CcSEcCtD
Tranexamic Acid—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000181	0.00172	CcSEcCtD
Tranexamic Acid—Discomfort—Triamcinolone—multiple sclerosis	0.000181	0.00171	CcSEcCtD
Tranexamic Acid—Discomfort—Methylprednisolone—multiple sclerosis	0.000181	0.00171	CcSEcCtD
Tranexamic Acid—Headache—Azathioprine—multiple sclerosis	0.00018	0.00171	CcSEcCtD
Tranexamic Acid—Renal failure—Methotrexate—multiple sclerosis	0.000179	0.00169	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—GPC5—multiple sclerosis	0.000178	0.00304	CbGpPWpGaD
Tranexamic Acid—Angiopathy—Prednisone—multiple sclerosis	0.000177	0.00168	CcSEcCtD
Tranexamic Acid—Immune system disorder—Prednisone—multiple sclerosis	0.000176	0.00167	CcSEcCtD
Tranexamic Acid—Malaise—Dexamethasone—multiple sclerosis	0.000176	0.00167	CcSEcCtD
Tranexamic Acid—Malaise—Betamethasone—multiple sclerosis	0.000176	0.00167	CcSEcCtD
Tranexamic Acid—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000176	0.00166	CcSEcCtD
Tranexamic Acid—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000175	0.00166	CcSEcCtD
Tranexamic Acid—Arrhythmia—Prednisone—multiple sclerosis	0.000174	0.00165	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000172	0.00163	CcSEcCtD
Tranexamic Acid—Loss of consciousness—Betamethasone—multiple sclerosis	0.000172	0.00163	CcSEcCtD
Tranexamic Acid—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000172	0.00163	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000171	0.00162	CcSEcCtD
Tranexamic Acid—Nausea—Azathioprine—multiple sclerosis	0.000171	0.00162	CcSEcCtD
Tranexamic Acid—Convulsion—Betamethasone—multiple sclerosis	0.000169	0.0016	CcSEcCtD
Tranexamic Acid—Convulsion—Dexamethasone—multiple sclerosis	0.000169	0.0016	CcSEcCtD
Tranexamic Acid—Asthenia—Mitoxantrone—multiple sclerosis	0.000167	0.00158	CcSEcCtD
Tranexamic Acid—Myalgia—Betamethasone—multiple sclerosis	0.000166	0.00157	CcSEcCtD
Tranexamic Acid—Myalgia—Dexamethasone—multiple sclerosis	0.000166	0.00157	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—MAPK1—multiple sclerosis	0.000166	0.00283	CbGpPWpGaD
Tranexamic Acid—Discomfort—Dexamethasone—multiple sclerosis	0.000164	0.00156	CcSEcCtD
Tranexamic Acid—Discomfort—Betamethasone—multiple sclerosis	0.000164	0.00156	CcSEcCtD
Tranexamic Acid—Haemoglobin—Methotrexate—multiple sclerosis	0.000164	0.00155	CcSEcCtD
Tranexamic Acid—Hypotension—Methylprednisolone—multiple sclerosis	0.000164	0.00155	CcSEcCtD
Tranexamic Acid—Haemorrhage—Methotrexate—multiple sclerosis	0.000163	0.00155	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—IL2RA—multiple sclerosis	0.000163	0.00278	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000162	0.00276	CbGpPWpGaD
Tranexamic Acid—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.00016	0.00152	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.00016	0.00151	CcSEcCtD
Tranexamic Acid—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000159	0.00151	CcSEcCtD
Tranexamic Acid—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000159	0.00151	CcSEcCtD
Tranexamic Acid—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000159	0.00151	CcSEcCtD
Tranexamic Acid—Ill-defined disorder—Prednisone—multiple sclerosis	0.000158	0.00149	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Prednisolone—multiple sclerosis	0.000157	0.00149	CcSEcCtD
Tranexamic Acid—Visual impairment—Methotrexate—multiple sclerosis	0.000157	0.00149	CcSEcCtD
Tranexamic Acid—Anaemia—Prednisone—multiple sclerosis	0.000157	0.00149	CcSEcCtD
Tranexamic Acid—Dyspnoea—Triamcinolone—multiple sclerosis	0.000156	0.00148	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000156	0.00148	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Betamethasone—multiple sclerosis	0.000156	0.00148	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—RGS1—multiple sclerosis	0.000156	0.00266	CbGpPWpGaD
Tranexamic Acid—Dyspepsia—Triamcinolone—multiple sclerosis	0.000155	0.00146	CcSEcCtD
Tranexamic Acid—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000154	0.00146	CcSEcCtD
Tranexamic Acid—Malaise—Prednisone—multiple sclerosis	0.000153	0.00145	CcSEcCtD
Tranexamic Acid—Eye disorder—Methotrexate—multiple sclerosis	0.000152	0.00144	CcSEcCtD
Tranexamic Acid—PLG—Extracellular matrix organization—MMP9—multiple sclerosis	0.000152	0.0026	CbGpPWpGaD
Tranexamic Acid—Cardiac disorder—Methotrexate—multiple sclerosis	0.000151	0.00143	CcSEcCtD
Tranexamic Acid—Fatigue—Triamcinolone—multiple sclerosis	0.000151	0.00143	CcSEcCtD
Tranexamic Acid—Fatigue—Methylprednisolone—multiple sclerosis	0.000151	0.00143	CcSEcCtD
Tranexamic Acid—Loss of consciousness—Prednisone—multiple sclerosis	0.000149	0.00142	CcSEcCtD
Tranexamic Acid—Hypotension—Betamethasone—multiple sclerosis	0.000149	0.00141	CcSEcCtD
Tranexamic Acid—Hypotension—Dexamethasone—multiple sclerosis	0.000149	0.00141	CcSEcCtD
Tranexamic Acid—Angiopathy—Methotrexate—multiple sclerosis	0.000148	0.0014	CcSEcCtD
Tranexamic Acid—Vomiting—Mitoxantrone—multiple sclerosis	0.000148	0.0014	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—GPR65—multiple sclerosis	0.000148	0.00252	CbGpPWpGaD
Tranexamic Acid—Immune system disorder—Methotrexate—multiple sclerosis	0.000147	0.0014	CcSEcCtD
Tranexamic Acid—Convulsion—Prednisone—multiple sclerosis	0.000147	0.0014	CcSEcCtD
Tranexamic Acid—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000147	0.00139	CcSEcCtD
Tranexamic Acid—Headache—Mitoxantrone—multiple sclerosis	0.000146	0.00138	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000145	0.00138	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000145	0.00138	CcSEcCtD
Tranexamic Acid—Arthralgia—Prednisone—multiple sclerosis	0.000145	0.00137	CcSEcCtD
Tranexamic Acid—Myalgia—Prednisone—multiple sclerosis	0.000145	0.00137	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000145	0.00137	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	0.000145	0.00247	CbGpPWpGaD
Tranexamic Acid—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000144	0.00137	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000143	0.00136	CcSEcCtD
Tranexamic Acid—Discomfort—Prednisone—multiple sclerosis	0.000143	0.00135	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	0.000142	0.00242	CbGpPWpGaD
Tranexamic Acid—Hypersensitivity—Prednisolone—multiple sclerosis	0.000141	0.00133	CcSEcCtD
Tranexamic Acid—Dyspepsia—Betamethasone—multiple sclerosis	0.00014	0.00133	CcSEcCtD
Tranexamic Acid—Dyspepsia—Dexamethasone—multiple sclerosis	0.00014	0.00133	CcSEcCtD
Tranexamic Acid—Anaphylactic shock—Prednisone—multiple sclerosis	0.000139	0.00131	CcSEcCtD
Tranexamic Acid—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000138	0.00131	CcSEcCtD
Tranexamic Acid—Nausea—Mitoxantrone—multiple sclerosis	0.000138	0.00131	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000137	0.0013	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000137	0.0013	CcSEcCtD
Tranexamic Acid—Back pain—Methotrexate—multiple sclerosis	0.000137	0.0013	CcSEcCtD
Tranexamic Acid—Fatigue—Betamethasone—multiple sclerosis	0.000137	0.0013	CcSEcCtD
Tranexamic Acid—Fatigue—Dexamethasone—multiple sclerosis	0.000137	0.0013	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Prednisone—multiple sclerosis	0.000136	0.00129	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—CCR1—multiple sclerosis	0.000135	0.00231	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CXCL13—multiple sclerosis	0.000135	0.00231	CbGpPWpGaD
Tranexamic Acid—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000132	0.00125	CcSEcCtD
Tranexamic Acid—Anaemia—Methotrexate—multiple sclerosis	0.000131	0.00124	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Betamethasone—multiple sclerosis	0.000131	0.00124	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000131	0.00124	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.00013	0.00123	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.00013	0.00123	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000129	0.00123	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000129	0.00122	CcSEcCtD
Tranexamic Acid—Malaise—Methotrexate—multiple sclerosis	0.000128	0.00121	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—IL6—multiple sclerosis	0.000127	0.00217	CbGpPWpGaD
Tranexamic Acid—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000126	0.0012	CcSEcCtD
Tranexamic Acid—Dizziness—Prednisolone—multiple sclerosis	0.000126	0.0012	CcSEcCtD
Tranexamic Acid—Asthenia—Triamcinolone—multiple sclerosis	0.000126	0.00119	CcSEcCtD
Tranexamic Acid—Abdominal pain—Betamethasone—multiple sclerosis	0.000126	0.00119	CcSEcCtD
Tranexamic Acid—Abdominal pain—Dexamethasone—multiple sclerosis	0.000126	0.00119	CcSEcCtD
Tranexamic Acid—Asthenia—Methylprednisolone—multiple sclerosis	0.000126	0.00119	CcSEcCtD
Tranexamic Acid—PLG—Extracellular matrix organization—TGFB1—multiple sclerosis	0.000125	0.00214	CbGpPWpGaD
Tranexamic Acid—Convulsion—Methotrexate—multiple sclerosis	0.000123	0.00117	CcSEcCtD
Tranexamic Acid—Dyspepsia—Prednisone—multiple sclerosis	0.000122	0.00116	CcSEcCtD
Tranexamic Acid—Arthralgia—Methotrexate—multiple sclerosis	0.000121	0.00115	CcSEcCtD
Tranexamic Acid—Myalgia—Methotrexate—multiple sclerosis	0.000121	0.00115	CcSEcCtD
Tranexamic Acid—Chest pain—Methotrexate—multiple sclerosis	0.000121	0.00115	CcSEcCtD
Tranexamic Acid—Diarrhoea—Methylprednisolone—multiple sclerosis	0.00012	0.00114	CcSEcCtD
Tranexamic Acid—Fatigue—Prednisone—multiple sclerosis	0.00012	0.00113	CcSEcCtD
Tranexamic Acid—Headache—Prednisolone—multiple sclerosis	0.00012	0.00113	CcSEcCtD
Tranexamic Acid—Discomfort—Methotrexate—multiple sclerosis	0.000119	0.00113	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—ALB—multiple sclerosis	0.000118	0.00201	CbGpPWpGaD
Tranexamic Acid—Dizziness—Triamcinolone—multiple sclerosis	0.000116	0.0011	CcSEcCtD
Tranexamic Acid—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000116	0.0011	CcSEcCtD
Tranexamic Acid—Dizziness—Methylprednisolone—multiple sclerosis	0.000116	0.0011	CcSEcCtD
Tranexamic Acid—SLC15A2—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.000115	0.00196	CbGpPWpGaD
Tranexamic Acid—Feeling abnormal—Prednisone—multiple sclerosis	0.000114	0.00108	CcSEcCtD
Tranexamic Acid—Asthenia—Dexamethasone—multiple sclerosis	0.000114	0.00108	CcSEcCtD
Tranexamic Acid—Asthenia—Betamethasone—multiple sclerosis	0.000114	0.00108	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Methotrexate—multiple sclerosis	0.000114	0.00108	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000113	0.00107	CcSEcCtD
Tranexamic Acid—Nausea—Prednisolone—multiple sclerosis	0.000113	0.00107	CcSEcCtD
Tranexamic Acid—Vomiting—Triamcinolone—multiple sclerosis	0.000112	0.00106	CcSEcCtD
Tranexamic Acid—Vomiting—Methylprednisolone—multiple sclerosis	0.000111	0.00106	CcSEcCtD
Tranexamic Acid—Headache—Triamcinolone—multiple sclerosis	0.00011	0.00104	CcSEcCtD
Tranexamic Acid—Headache—Methylprednisolone—multiple sclerosis	0.00011	0.00104	CcSEcCtD
Tranexamic Acid—Abdominal pain—Prednisone—multiple sclerosis	0.00011	0.00104	CcSEcCtD
Tranexamic Acid—Diarrhoea—Dexamethasone—multiple sclerosis	0.000109	0.00103	CcSEcCtD
Tranexamic Acid—Diarrhoea—Betamethasone—multiple sclerosis	0.000109	0.00103	CcSEcCtD
Tranexamic Acid—Hypotension—Methotrexate—multiple sclerosis	0.000108	0.00103	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000106	0.001	CcSEcCtD
Tranexamic Acid—Dizziness—Betamethasone—multiple sclerosis	0.000105	0.000998	CcSEcCtD
Tranexamic Acid—Dizziness—Dexamethasone—multiple sclerosis	0.000105	0.000998	CcSEcCtD
Tranexamic Acid—Nausea—Triamcinolone—multiple sclerosis	0.000104	0.000988	CcSEcCtD
Tranexamic Acid—Nausea—Methylprednisolone—multiple sclerosis	0.000104	0.000986	CcSEcCtD
Tranexamic Acid—Dyspnoea—Methotrexate—multiple sclerosis	0.000103	0.000979	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Prednisone—multiple sclerosis	0.000102	0.000968	CcSEcCtD
Tranexamic Acid—Dyspepsia—Methotrexate—multiple sclerosis	0.000102	0.000967	CcSEcCtD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.000102	0.00174	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—POMC—multiple sclerosis	0.000102	0.00174	CbGpPWpGaD
Tranexamic Acid—Vomiting—Betamethasone—multiple sclerosis	0.000101	0.00096	CcSEcCtD
Tranexamic Acid—Vomiting—Dexamethasone—multiple sclerosis	0.000101	0.00096	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.0001	0.000948	CcSEcCtD
Tranexamic Acid—Fatigue—Methotrexate—multiple sclerosis	9.99e-05	0.000947	CcSEcCtD
Tranexamic Acid—Headache—Betamethasone—multiple sclerosis	9.98e-05	0.000946	CcSEcCtD
Tranexamic Acid—Headache—Dexamethasone—multiple sclerosis	9.98e-05	0.000946	CcSEcCtD
Tranexamic Acid—Asthenia—Prednisone—multiple sclerosis	9.95e-05	0.000943	CcSEcCtD
Tranexamic Acid—PLG—Metabolism of proteins—CCL2—multiple sclerosis	9.95e-05	0.0017	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CCL3—multiple sclerosis	9.62e-05	0.00164	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—IL2—multiple sclerosis	9.56e-05	0.00163	CbGpPWpGaD
Tranexamic Acid—Feeling abnormal—Methotrexate—multiple sclerosis	9.55e-05	0.000905	CcSEcCtD
Tranexamic Acid—Diarrhoea—Prednisone—multiple sclerosis	9.49e-05	0.000899	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Methotrexate—multiple sclerosis	9.48e-05	0.000898	CcSEcCtD
Tranexamic Acid—Nausea—Dexamethasone—multiple sclerosis	9.46e-05	0.000897	CcSEcCtD
Tranexamic Acid—Nausea—Betamethasone—multiple sclerosis	9.46e-05	0.000897	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—PTGER4—multiple sclerosis	9.26e-05	0.00158	CbGpPWpGaD
Tranexamic Acid—Dizziness—Prednisone—multiple sclerosis	9.17e-05	0.000869	CcSEcCtD
Tranexamic Acid—Abdominal pain—Methotrexate—multiple sclerosis	9.16e-05	0.000868	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—PGR—multiple sclerosis	9.12e-05	0.00156	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CXCR3—multiple sclerosis	8.95e-05	0.00153	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CD28—multiple sclerosis	8.86e-05	0.00151	CbGpPWpGaD
Tranexamic Acid—Vomiting—Prednisone—multiple sclerosis	8.82e-05	0.000836	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—CCR2—multiple sclerosis	8.7e-05	0.00149	CbGpPWpGaD
Tranexamic Acid—Headache—Prednisone—multiple sclerosis	8.69e-05	0.000823	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Methotrexate—multiple sclerosis	8.54e-05	0.000809	CcSEcCtD
Tranexamic Acid—Asthenia—Methotrexate—multiple sclerosis	8.32e-05	0.000788	CcSEcCtD
Tranexamic Acid—Nausea—Prednisone—multiple sclerosis	8.24e-05	0.000781	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—CNR1—multiple sclerosis	8.03e-05	0.00137	CbGpPWpGaD
Tranexamic Acid—Diarrhoea—Methotrexate—multiple sclerosis	7.93e-05	0.000752	CcSEcCtD
Tranexamic Acid—Dizziness—Methotrexate—multiple sclerosis	7.67e-05	0.000726	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—TGFB1—multiple sclerosis	7.46e-05	0.00127	CbGpPWpGaD
Tranexamic Acid—Vomiting—Methotrexate—multiple sclerosis	7.37e-05	0.000698	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—MAPK1—multiple sclerosis	7.31e-05	0.00125	CbGpPWpGaD
Tranexamic Acid—Headache—Methotrexate—multiple sclerosis	7.26e-05	0.000688	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—CXCL10—multiple sclerosis	7.23e-05	0.00124	CbGpPWpGaD
Tranexamic Acid—Nausea—Methotrexate—multiple sclerosis	6.89e-05	0.000652	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—CD86—multiple sclerosis	6.32e-05	0.00108	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CCL5—multiple sclerosis	6.22e-05	0.00106	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	5.82e-05	0.000995	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—SPP1—multiple sclerosis	5.76e-05	0.000985	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CCR5—multiple sclerosis	5.61e-05	0.000958	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—IL2RA—multiple sclerosis	5.53e-05	0.000944	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—APOE—multiple sclerosis	5.1e-05	0.000872	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CD80—multiple sclerosis	4.61e-05	0.000788	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—POMC—multiple sclerosis	4.38e-05	0.000749	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CCL2—multiple sclerosis	4.29e-05	0.000733	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—TYK2—multiple sclerosis	3.89e-05	0.000665	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—IL2—multiple sclerosis	3.24e-05	0.000554	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—MMP9—multiple sclerosis	3.07e-05	0.000524	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—STAT3—multiple sclerosis	2.73e-05	0.000466	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—MYC—multiple sclerosis	2.53e-05	0.000433	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—TGFB1—multiple sclerosis	2.53e-05	0.000432	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—MAPK1—multiple sclerosis	2.48e-05	0.000423	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—IL6—multiple sclerosis	1.9e-05	0.000325	CbGpPWpGaD
